MUC1 and cancer: As hypoglycosylated MUC1 is such a prevalent tumor-specific antigen found on a wide variety of human tumors, further development of these and additional antibodies that are being generated using our approach into cancer immunotherapeutic reagents has the potential to aid in the treatment of a very large number of cancer patients.